A Network Pharmacology and Molecular Dynamics Simulation-Based Study of Qing Run Hua Jie Decoction in Interstitial Pneumonia Treatment
Chunxiang Li,Yingbin Lian,Yaoshen Lin,Zhihua Li
DOI: https://doi.org/10.2147/idr.s433755
2024-02-16
Infection and Drug Resistance
Abstract:Chunxiang Li, 1, &ast Yingbin Lian, 1, &ast Yaoshen Lin, 1 Zhihua Li 2 1 Department of Integrative Medicine Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, 362000, People's Republic of China; 2 Department of Oncology, Zhangzhou Second Hospital, Zhangzhou, Fujian, 363199, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhihua Li, Department of Oncology, Zhangzhou Second Hospital, No. 35, Ziwei Road, Shima Town, Longhai District, Zhangzhou, Fujian, 363199, People's Republic of China, Tel +86-13459666448, Email Objective: This study is dedicated to revealing the potential mechanism of Qin Run Hua Jie (QRHJ) decoction in Interstitial pneumonia (IP) treatment. Methods: The TCMSP database predicted the chemical components and targets of QRHJ decoction, and the IP-related genes were from the Genecards database. Cytoscape software was used to establish the interaction network. R package clusterProfiler was utilized for Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. The molecular docking analysis of target proteins and the corresponding active pharmaceutical ingredients in the core position of the interaction network was conducted. Then, molecular dynamics (MD) simulations of a potential active substance and its key targets were performed. The binding efficiency of EGFR and luteolin, HIF1A and diosgenin was detected by cellular thermal shift assay (CETSA), and protein expression was measured by Western blot. CCK-8 was used to detect cell activity. Results: A total of 153 active ingredients, 127 targets and 362 IP-related genes were obtained. KEGG enrichment analysis identified IP-related signaling pathways including HIF-1 signaling pathway and TNF signaling pathway. The two key components luteolin and diosgenin stably bound to the key targets EGFR and HIF1A. Cell experiments further showed that EGFR and luteolin, HIF1A and diosgenin bound to exert anti-fibrotic effects. Conclusion: As an active ingredient of QRHJ decoction, luteolin and diosgenin may exert therapeutic effect on IP through binding to the key target EGFR and HIF1A. This work initially revealed the key molecular mechanism of QRHJ decoction in IP treatment and offered theoretical evidence. Keywords: Qing Run Hua Jie decoction, interstitial pneumonia, network pharmacology, molecular docking, molecular dynamics As a group of diffuse parenchymal diseases characterized by inflammation and fibrosis of the pulmonary parenchyma, 1,2 interstitial pneumonia (IP) has over 200 different pathologies with known and unknown causes. 3 Idiopathic pulmonary fibrosis is the most common and severe symptom in IP. 3 Identifying the cause is crucial to the eradication of IP, however, only symptomatic treatment is often applied due to unclear causes. Current regular treatments for IP include immunosuppressive drugs, anti-inflammatory and anti-fibrosis, which effectively slows down the hyperimmunity, inflammation and fibrotic process to a certain extent, but can hardly cure IP. 4,5 Therefore, it would be meaningful to develop new treatments for IP patients to improve their quality of life. The herbs used in traditional Chinese medicine (TCM) exert a holistic regulatory and synergistic effect through a multi-target and multi-pathway intervention strategy. In this regard, the employing of network pharmacology for illustrating the mechanism of drug action gets increasingly popular. As an integrated discipline, network pharmacology includes pharmacology, network physiology, bioinformatics and cheminformatics. 6 Network pharmacology offers new ideas for TCM and novel drug study, since its research strategy echoes with the holistic view of TCM theory. 7 Network pharmacology has been commonly used in medical research currently. Chen et al 8 constructed a network of herbs and components by screening potential targets of TCM for cough variant asthma treatment through network pharmacology and determined the efficacy by seeking relevant pathways. Tang et al 9 found that 3 substances in Tripterygium wilfordii, Sedum acre and Hypericum patulum can bind to the zinc-binding site of matrix metalloproteinase-9, which exerts a crucial effect on acute skin inflammation. In this way, the side effects of tetracycline can be avoided, while the efficacy can be improved through a high-throughput virtual screening method of network pharmacology, which can be further developed as a new therapy for acute skin inflammation. 9 These studies confirm that network pharmacology offers new insight into disease tr -Abstract Truncated-
pharmacology & pharmacy,infectious diseases